Life Sciences Firms Scale Trusted AI Decision Systems
Key Highlights
- ➤ISG report says life sciences firms are scaling AI for faster, better-informed decisions.
- ➤Nine providers named Leaders in ISG’s Specialty Analytics and AI Services quadrant.
- ➤Infocepts named Rising Star for its promising portfolio and high future potential.
- ➤HCLTech named 2026 global ISG CX Star Performer for life sciences providers.
Expert Statements
Jenn Stein, Partner and industry leader, ISG Life and Health Sciences
“The next test is whether companies can turn the growing volume and variety of scientific data into decisions people will trust”
Jenn Stein, Partner and industry leader, ISG Life and Health Sciences
“In life sciences, an AI output has little value if its evidence and limitations cannot be inspected by researchers, clinicians and regulators.”
Manav Deep Sachdeva, ISG principal analyst and lead author of the report
“The market will take shape around bounded AI workflows that remove friction while preserving expert accountability”
Manav Deep Sachdeva, ISG principal analyst and lead author of the report
“Leading providers will be able to redesign workflows and roles and sustain hybrid human-AI operations as buyers move from demonstrations to measurable production results.”
Organizations adopt AI and analytics to integrate scientific data, shorten development cycles and improve decisions, ISG Provider Lens(®) report says
Life sciences companies are seeking validated capabilities that transform data into actionable insights for daily research, clinical and commercial work, according to a new research report published today by Information Services Group (ISG ) (Nasdaq: III ), a global AI-centered technology research and advisory firm.
Get started
Create a free account to read the full story.